Back to Search

SUSAN MATHER, MD

MD

Internal Medicine Physician

NPI: 1790717031Individual

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

MD070004L(PA)

Research & Publications (20)

Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy.
PMID 17401100·J Nucl Med·2007
7-preclinical
Rapid endothelial cell-selective loading of connexin 40 antibody blocks endothelium-derived hyperpolarizing factor dilation in rat small mesenteric arteries.
PMID 16037574·Circ Res·2005
7-preclinical
99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo.
PMID 19289435·J Nucl Med·2009
7-preclinical
Cancer-specific transgene expression mediated by systemic injection of nanoparticles.
PMID 19258509·Cancer Res·2009
7-preclinical
Bifunctional bisphosphonate complexes for the diagnosis and therapy of bone metastases.
PMID 19652801·Chem Commun (Camb)·2009
7-preclinical
Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids.
PMID 19447500·J Inorg Biochem·2009
7-preclinical
Radiopharmaceutical clinical trials - dose is more than sieverts and becquerels.
PMID 19288100·Eur J Nucl Med Mol Imaging·2009
8-other
Molecular imaging with bioconjugates in mouse models of cancer.
PMID 19086866·Bioconjug Chem·2009
6-review
Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.
PMID 19591486·J Med Chem·2009
7-preclinical
A novel model for the pre-clinical imaging of inflamed human synovial vasculature.
PMID 19491304·Rheumatology (Oxford)·2009
7-preclinical
Recombinant human VEGF165b protein is an effective anti-cancer agent in mice.
PMID 18657413·Eur J Cancer·2008
7-preclinical
99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study.
PMID 18542959·Eur J Nucl Med Mol Imaging·2008
3-trial
99mTc-labelled rituximab, a new non-Hodgkin's lymphoma imaging agent: first clinical experience.
PMID 18987526·Nucl Med Commun·2008
3-trial
Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor.
PMID 18354214·J Immunol·2008
8-other
Pancreatic scintigraphy with 99mTc-interleukin-2 at diagnosis of type 1 diabetes and after 1 year of nicotinamide therapy.
PMID 17918277·Diabetes Metab Res Rev·2008
4-observational
Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging study.
PMID 17387005·Eur J Pharm Sci·2007
4-observational
SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene.
PMID 17960161·Gene Ther·2007
7-preclinical
How do HYNIC-conjugated peptides bind technetium? Insights from LC-MS and stability studies.
PMID 17992285·Dalton Trans·2007
8-other
In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
PMID 17383579·Nucl Med Biol·2007
4-observational
Trifluoroacetyl-HYNIC peptides: synthesis and 99mTc radiolabeling.
PMID 17315986·J Med Chem·2007
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
833 CHESTNUT STREET, SUITE 220
PHILADELPHIA, PA 19107

Location

Practice Location

833 CHESTNUT STREET, PHILADELPHIA, PA
(215) 955-8465

Quick Facts

NPI
1790717031
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile